Pontillo G, Prados F, Wink AM, Kanber B, Bisecco A, Broeders TAA, Brunetti A, Cagol A, Calabrese M, Castellaro M, Cocozza S, Colato E, Collorone S, Cortese R, De Stefano N, Douw L, Enzinger C, Filippi M, Foster MA, Gallo A, Gonzalez-Escamilla G, Granziera C, Groppa S, Harbo HF, Høgestøl EA et al. (2025)
More Than the Sum of Its Parts: Disrupted Core Periphery of Multiplex Brain Networks in Multiple Sclerosis
Hum Brain Mapp, 46 (1), e70107
DOI 10.1002/hbm.70107, PubMed 39740239

Rød BE, Høgestøl EA, Torkildsen Ø, Bjørnevik K, Gran JM, Øverås MH, König M, Myhr KM, Wergeland S, Nygaard GO (2025)
Comparative effectiveness of rituximab and cladribine in relapsing-remitting multiple sclerosis: A target trial emulation
Mult Scler, 31 (8), 975-984
DOI 10.1177/13524585251342727, PubMed 40415655

Skattebøl L, Lundby R, Øverås MH, Sowa P, Celius EG, Harbo HF, Nordhøy W, Høgestøl EA, Nygaard GO (2025)
Quantitative susceptibility mapping of paramagnetic rim lesions in early multiple sclerosis: A cross-sectional study of brain age and disability
Neuroimage Rep, 5 (3), 100277
DOI 10.1016/j.ynirp.2025.100277, PubMed 41050950